Notizie sul Mercato Azionario
Ultime notizie finanziarie · Aggiornato Mag 23, 2026
Perché il titolo Palo Alto Networks è sceso oggi
Why Palo Alto Networks Stock Dropped Today
The panel generally agreed that the 7% drop in PANW was due to overvaluation and unfounded rumors about Anthropic's Claude …
Eli Lilly vs Novo Nordisk: Qual è il miglior titolo farmaceutico per l'obesità?
Eli Lilly vs Novo Nordisk: Which Obesity Drug Stock Is the Better Buy?
The discussion panel is divided on the valuation of Eli Lilly (LLY) and Novo Nordisk (NVO). While some argue LLY's …
Previsione: Ethereum Supererà Bitcoin nei Prossimi 3 Anni
Prediction: Ethereum Will Outperform Bitcoin Over the Next 3 Years
The panel's net takeaway is that Ethereum's (ETH) potential to outperform Bitcoin (BTC) over the next three years is uncertain …
Azioni di Zenas BioPharma in calo del 20% dopo l'annuncio di offerte per 300 milioni di dollari
Zenas BioPharma Stock Falls 20% After Pricing $300 Mln Offerings
The panel is divided on ZBIO's recent capital raise. While some see it as funding runway to key catalysts and …
EEM, UST: Grandi deflussi dagli ETF
EEM, UST: Big ETF Outflows
The panel agrees that the 35.9% outflow from UST signals a significant de-risking from long-duration bets, likely driven by rising …
1 ETF a Basso Costo Che Potrebbe Superare i Fondi Gestiti Attivamente Quest'Anno
1 Low-Cost ETF That Could Outperform Actively Managed Funds This Year
The panel agreed that VOO's heavy concentration in the 'Magnificent Seven' (33% weight) exposes it to tech/AI bubble risks, particularly …
CORO, EWJ, EWC, EWU: Allarme di afflusso ETF
CORO, EWJ, EWC, EWU: ETF Inflow Alert
The panelists agree that the article's analysis of CORO's inflows is flawed due to missing data and potential ticker confusion. …
AtaiBeckley ottiene la valutazione 'Buy' nella copertura iniziale degli analisti di Deutsche Bank
AtaiBeckley awarded ‘Buy’ rating in initial coverage from Deutsche Bank analysts
The panelists generally agreed that Deutsche Bank's $12 price target for ATAI Life Sciences, implying 320% upside, is overly optimistic …
I farmaci a basso rischio di Protagonist Therapeutics (PTGX) hanno un potenziale da blockbuster?
Do Protagonist Therapeutics’ (PTGX) Derisked Drugs Have Blockbuster Potential?
The panel is neutral on Protagonist Therapeutics (PTGX) at a $6.3B market cap, with concerns about competition in the IBD …
L’indagine della CMA del Regno Unito su Just Eat per recensioni online fuorvianti
UK’s CMA probes Just Eat over misleading online ratings
The consensus among the panel is that the CMA's fact-finding probe into Just Eat's ratings system poses significant risks, primarily …
Un tribunale d'appello statunitense annulla una sentenza da 16,1 miliardi di dollari contro l'Argentina per il sequestro di YPF
US appeals court voids $16.1 billion judgment against Argentina over YPF seizure
The 2nd Circuit's ruling voids a major US-law legal overhang, providing immediate fiscal relief to Argentina and improving Milei's negotiating …
Logica, Logistica E Almeno Altri 10 Giorni...
Logic, Logistics, And At Least Another 10 Days...
The panel agrees that the extension to April 6 increases geopolitical risks, with potential impacts on oil prices, insurance costs, …